Pharmaresearch is enhancing its academic marketing for its flagship product, 'Rejuran,' focusing on its aesthetic product line. The strategy aims to broaden lectures and academic exchanges for medical professionals to communicate the scientific basis and clinical applicability of its products.
On October 22, Pharmaresearch announced that it is strengthening academic activities related to its key aesthetic products, including Rejuran, 'Evercle,' and 'Rejuderma.' The company plans to share scientific principles and clinical experiences for each product to improve medical professionals' understanding and discuss clinical considerations and applications based on treatment objectives.
The company participated in the Korean Obesity and Aesthetic Medicine Society (KOAT) academic event and the Korean Functional Aesthetic Medicine Society (KFCC) fall academic conference on October 18, where it conducted lectures related to its major products.
At the KOAT event, clinical experiences with Rejuran and Evercle were shared. Lee Kyung-hwan, a project director at the clinic and a cooperating director of KOAT, delivered a lecture titled 'The Evolution of Skin Rejuvenation: Designing Synergy Protocols with DOT PN and PLLA.' PN (polynucleotide) is a polymer derived from DNA used in skin aesthetic procedures, while PLLA (poly-L-lactic acid) is a biodegradable polymer that induces collagen production in aesthetic treatments. Rejuran is based on PN, and Evercle is based on PLLA.
At the KFCC fall academic conference held the same day, lectures continued on the scientific principles and clinical applications of Rejuran, Evercle, and Rejuderma. Kim Michael, executive director of medical strategy at Pharmaresearch, presented on the scaffold structure of Rejuran's 'DOT polynucleotide' and its structural differences from PDRN (polydeoxyribonucleotide).
Park Hyun-jun, director of Meilin Clinic, introduced the aesthetic and functional medical value of Evercle and its clinical applications. Hwang Won-wook, director of Cheongdam Revelle Clinic, explained the functional medical approach to skin barrier damage and the recovery mechanisms through Rejuderma. Park Kyung-min, director of Seongsu Melting Clinic, discussed strategies for preserving lean body mass during GLP-1 treatment, presenting a functional medical approach using placental extracts.
A Pharmaresearch representative stated, "We were able to deeply convey the excellence and clinical value of our regenerative medicine-based aesthetic portfolio to medical professionals. We will continue to expand academic exchanges to share various experiences and cases from clinical practice."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.